The Science of Certainty: How DNA Paternity Tests Work

Establishing biological kinship was once a matter of physical resemblance and blood typing, methods that offered high margins of error and limited exclusionary power. Today, the landscape has shifted toward the molecular level. A study published in Forensic Science International (Butler, 2015) highlights that modern Short Tandem Repeat (STR) analysis has reached a level of statistical power where the probability of paternity can routinely exceed 99.999%. In our clinical practice at BioGenetic, we observe that this certainty is not merely a mathematical abstraction but the result of rigorous genomic sequencing and the application of Population Genetics. Understanding the mechanics of these tests is essential for both legal clarity and personal peace of mind.

The Molecular Foundation: Short Tandem Repeats (STRs)

The human genome consists of approximately three billion base pairs. While 99.9% of this sequence is identical across all humans, the remaining 0.1% contains the variations that define individuality. For paternity testing, we do not sequence the entire genome; instead, we focus on specific loci known as Short Tandem Repeats (STRs). These are non-coding regions where a short sequence of DNA (typically 2 to 5 base pairs) repeats a variable number of times.

When we analyze these regions, we are looking at alleles. Every individual inherits one allele from their biological mother and one from their biological father at every given locus. In a standard laboratory workflow, we extract DNA from buccal swabs—which gather epithelial cells from the inside of the cheek—and amplify these STR regions using Polymerase Chain Reaction (PCR). This process creates millions of copies of the specific DNA segments, allowing us to measure their length with precision.

By comparing the genetic profile of the child with the alleged father, we can determine if the father contributes the necessary alleles to the child’s profile. If the child possesses an allele at a specific locus that does not match either the mother or the alleged father, that locus constitutes a "mismatch." In modern diagnostics, we typically analyze between 21 and 24 loci to ensure that the statistical overlap is not the result of a random occurrence within the general population.

The Probability of Paternity and the PI Calculation

A common question we address in our consultations involves the "99.9%" figure. In genetics, we rarely speak of 100% certainty because, theoretically, an identical twin or a very close male relative could share the same genetic markers. Instead, we calculate the Paternity Index (PI). This is a likelihood ratio that compares two hypotheses: first, that the alleged father is the biological father; and second, that an unrelated, random man from the same ethnic population is the father.

The Combined Paternity Index (CPI) is the product of the individual Paternity Indices for every locus tested. If we find a CPI of 1,000,000, it means the alleged father is one million times more likely to be the biological father than a random person. This is then converted into a "Probability of Paternity." According to guidelines established by the American Association of Blood Banks (AABB), which frequently inform standards across Latin America, a probability of 99% or higher is generally accepted as proof of paternity. However, with the high-density kits used at BioGenetic, we often see figures reaching 99.9999%, effectively eliminating the possibility of a false inclusion.

Legal Validity versus Informative Testing

In the Latin American context, the distinction between a "legal" test and an "informative" (or "home") test is a critical regulatory boundary. While the laboratory technology and the accuracy of the DNA analysis are identical in both cases, the difference lies in the chain of custody.

The informativo test is designed for personal knowledge. The samples are collected by the individuals themselves and sent to the lab. Because there is no third-party verification of the identity of the donors, these results cannot be used as evidence in a court of law. They serve to provide immediate answers for families without the institutional friction of a legal proceeding.

On the other hand, the legal paternity test requires a strict protocol. A neutral third party must collect the samples, verify the identities of all participants through official government documents (such as the DNI, Cédula de Identidad, or Passport), and ensure that the samples were never tampered with. This documentation allows the laboratory report to be admissible in cases of child support, inheritance disputes, or custody battles. At BioGenetic, we manage both types of processes, ensuring that the molecular data is supported by the necessary administrative rigor for each specific need.

Complex Scenarios: Mutations and Close Relatives

Not every paternity test provides a straightforward match at every single locus. Spontaneous genetic mutations occur in approximately 1 out of every 500 to 1,000 birth events. A mutation might mean that a child has a repeat value of 12 at a specific locus, while the father has an 11 or a 13. A single mismatch does not automatically result in an exclusion.

The International Society for Forensic Genetics (ISFG) provides specific guidelines for handling these "inconsistencies." When we encounter a single or double mismatch, we increase the number of loci tested to provide more data points. If the rest of the profile shows a strong match, we apply a "mutation rate" calculation to the statistical model. This ensures that a natural biological variation does not lead to a false exclusion of a biological father.

Furthermore, cases involving brothers or fathers and sons as potential candidates require specialized analysis. Because family members share a significant portion of their DNA, a standard 16-marker test might not provide enough resolution. In these instances, we employ expanded marker sets or Y-chromosome testing (Y-STR), which tracks the paternal lineage directly, to provide the necessary clarity. This is often the case in forensic investigations or complex inheritance cases where the primary alleged father is deceased or unavailable.

Modern Advancements: Non-Invasive Prenatal Paternity (NIPP)

The most significant technological leap in the last decade is the ability to determine paternity before the child is born. Traditionally, this required invasive procedures like amniocentesis, which carries a risk of miscarriage. However, a study in the New England Journal of Medicine (Lo et al., 2010) laid the groundwork for analyzing Cell-Free DNA (cfDNA).

During pregnancy, small fragments of fetal DNA cross the placenta and enter the mother's bloodstream. By taking a simple blood sample from the mother and a swab from the alleged father, we can isolate this fetal DNA. We then compare thousands of Single Nucleotide Polymorphisms (SNPs) to determine biological kinship. This method is highly accurate and can be performed as early as the seventh or eighth week of pregnancy. It offers a safe, non-invasive alternative for families who require answers during the prenatal period.

At BioGenetic, we understand that behind every genetic report is a family seeking truth. Whether it is an informative test for peace of mind or a legal test for judicial proceedings, the science of DNA offers a level of certainty that was unimaginable just a generation ago. Our commitment is to provide this precision through rigorous laboratory standards and expert interpretation.

If you are facing a situation that requires biological confirmation of paternity, the BioGenetic team is available to guide you through the process. We offer confidential orientations to help you choose the test that fits your legal or personal requirements. For more information on our services or to schedule a consultation, you may reach out to us via our dedicated WhatsApp channel for immediate assistance.

BioGenetic Team